GFACX
Price
$68.34
Change
+$0.06 (+0.09%)
Updated
Oct 17 closing price
JRARX
Price
$82.66
Change
+$0.17 (+0.21%)
Updated
Oct 17 closing price
Ad is loading...

GFACX vs JRARX

Header iconGFACX vs JRARX Comparison
Open Charts GFACX vs JRARXBanner chart's image
American Funds Growth Fund of Amer C
Price$68.34
Change+$0.06 (+0.09%)
VolumeN/A
CapitalizationN/A
Janus Henderson Research R
Price$82.66
Change+$0.17 (+0.21%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GFACX vs JRARX Comparison Chart
Loading...
VS
GFACX vs. JRARX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and JRARX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 296B vs. JRARX (23.8B). GFACX (0.00) and JRARX (0.00) have matching dividends . GFACX was incepted earlier than JRARX: GFACX (24 years) vs JRARX (8 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. JRARX (27.00). GFACX has a lower initial minimum investment than JRARX: GFACX (250) vs JRARX (2500). JRARX annual gain was more profitable for investors over the last year : 38.64 vs. GFACX (29.02). JRARX return over 5 years is better than : 66.24 vs. GFACX (50.43).
GFACXJRARXGFACX / JRARX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years8 years-
Gain YTD24.14529.68181%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets296B23.8B1,244%
Annual Yield % from dividends0.000.00-
Returns for 1 year29.0238.6475%
Returns for 3 years-3.3113.00-25%
Returns for 5 years50.4366.2476%
Returns for 10 years65.41N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LYFIX13.850.14
+1.02%
AlphaCentric LifeSci Healthcare I
OIEJX26.620.24
+0.91%
JPMorgan Equity Income R6
SGDLX58.670.39
+0.67%
Sprott Gold Equity Investor
LICQX15.960.08
+0.50%
Lord Abbett International Equity R2
ETGLX50.700.16
+0.32%
Eventide Gilead N